Effects of Itopride Hydrochloride on Plasma Gut-Regulatory Peptide and Stress-Related Hormone Levels in Healthy Human Subjects

Itopride hydrochloride (itopride), a gastrokinetic drug, has recently been evaluated for its clinical usefulness in functional dyspepsia. We investigated effects of itopride on human plasma gastrin-, somatostatin-, motilin-, and cholecystokinin (CCK)-like immunoreactive substances (IS); adrenocorticotropic hormone (ACTH)-immunoreactive substances (IS), and cortisol under stress conditions in healthy subjects. A single administration of itopride caused significant increases in plasma somatostatin- and motilin-IS levels compared to placebo. Itopride significantly decreased plasma CCK-IS, and suppressed the ACTH-IS level compared to placebo. We hypothesize that itopride may have an accelerating gastric emptying effect, and a modulatory effect on the hypothalamo-pituitary-adrenal axis and autonomic nervous functions. These effects might be beneficial in stress-related diseases, suggesting that itopride has clinicopharmacological activities.

[1]  Fumihiko Katagiri,et al.  Clinical application of an enzyme immunoassay for cholecystokinin‐like immunoreactive substance for determination of the human plasma levels: the effect of metoclopramide on gastrointestinal peptides and stress‐related hormones , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[2]  Fumihiko Katagiri,et al.  Comparison of the effects of cytoprotective drugs on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure. , 2005, Biological & pharmaceutical bulletin.

[3]  Fumihiko Katagiri,et al.  Ecabet sodium raises plasma levels of calcitonin gene‐related peptide and substance P in healthy humans , 2005, The Journal of pharmacy and pharmacology.

[4]  M. Otaka,et al.  New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline , 2005, Alimentary pharmacology & therapeutics.

[5]  B. Lohray,et al.  Quantitation of itopride in human serum by high-performance liquid chromatography with fluorescence detection and its application to a bioequivalence study. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  I. Szelenyi.  Cholinergic components in the gastrin pathway of gastric acid stimulation , 1980, Experientia.

[7]  N. Talley,et al.  Functional dyspepsia: drugs for new (and old) therapeutic targets. , 2004, Best practice & research. Clinical gastroenterology.

[8]  J. Grider.  Neurotransmitters Mediating the Intestinal Peristaltic Reflex in the Mouse , 2003, Journal of Pharmacology and Experimental Therapeutics.

[9]  N. Talley.  Evaluation of drug treatment in irritable bowel syndrome. , 2003, British journal of clinical pharmacology.

[10]  R. Herranz.  Cholecystokinin antagonists: Pharmacological and therapeutic potential , 2003, Medicinal research reviews.

[11]  T. Tsubouchi,et al.  Stimulatory Action of Itopride Hydrochloride on Colonic Motor Activity in Vitro and in Vivo , 2003, Journal of Pharmacology and Experimental Therapeutics.

[12]  S. Ishihara,et al.  Localization of calcitonin gene-related peptide receptors in rat gastric mucosa , 2002, Peptides.

[13]  H. Itoh,et al.  Hange-shashin-to raises levels of somatostatin, motilin, and gastrin in the plasma of healthy subjects. , 2002, Biological & pharmaceutical bulletin.

[14]  P. Vachon,et al.  Serum corticosterone and blood glucose in rats after two jugular vein blood sampling methods: comparison of the stress response. , 2001, Contemporary topics in laboratory animal science.

[15]  H. Itoh,et al.  Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. , 2001, Biological & pharmaceutical bulletin.

[16]  H. Itoh,et al.  Ranitidine Increases Bioavailability of Acetaminophen by Inhibiting First‐Pass Glucuronidation in Man , 2000 .

[17]  M. Camilleri,et al.  Functional gastroduodenal disorders , 1999, Gut.

[18]  H. Itoh,et al.  Enzyme Immunoassay of Adrenocorticotropic Hormone-like Immunoreactive Substance in Human Plasma , 1999 .

[19]  M. Hongo,et al.  Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.

[20]  A. Brooks,et al.  Dopaminergic regulation of adrenocorticotrophic hormone, alpha-melanocyte-stimulating hormone and cortisol secretion in the ovine fetus. , 1996, The Journal of endocrinology.

[21]  H. Matsuo,et al.  Enzyme immunoassay of gastrin in human plasma. , 1993, Chemical & pharmaceutical bulletin.

[22]  P. Poitras,et al.  Cholinergic regulation of motilin release from isolated canine intestinal cells , 1993, Peptides.

[23]  S. Lightman,et al.  Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. , 1992, The Journal of endocrinology.

[24]  Y. Kondo,et al.  A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. , 1990, Gastroenterology.

[25]  L. Kok,et al.  Psychosocial aspects of non-ulcer dyspepsia. , 1989, Singapore medical journal.

[26]  R. Ferriani,et al.  Effect of venipuncture stress on plasma prolactin levels , 1985, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  G. Vantrappen,et al.  Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism. , 1984, Gastroenterology.

[28]  D. K. Meyer,et al.  Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum. , 1984, European journal of pharmacology.

[29]  T. Yamada,et al.  Somatostatin-14 and -28: clearance and potency on gastric function in dogs. , 1982, The American journal of physiology.

[30]  B. McEwen,et al.  Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. , 1982, Neuroendocrinology.

[31]  T. Kitagawa,et al.  Preparation and Characterization of Hetero-bifunctional Cross-linking Reagents for Protein Modifications , 1981 .

[32]  E. Schrumpf.  The inhibitory action of somatostatin on the stomach. , 1978, Advances in experimental medicine and biology.

[33]  S. Miyabo,et al.  Growth hormone and cortisol responses to psychological stress: comparison of normal and neurotic subjects. , 1976, The Journal of clinical endocrinology and metabolism.

[34]  Z. Itoh,et al.  Motilin-induced mechanical activity in the canine alimentary tract. , 1976, Scandinavian journal of gastroenterology. Supplement.

[35]  N. Ling,et al.  The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone. , 1973, Biochemical and biophysical research communications.

[36]  T. Hiroshige,et al.  Stress-induced activation of phosphorylase in the rat adenohypophysis. , 1969, Endocrinologia japonica.